EcoDrugPlus

Histone Deacetylase 7

Ensembl ID : ENSSFOG00015016447
Gene Symbol: HDAC7
3 Cross references
189 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSSFOG00015009809
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2

Ensembl ID : ENSSFOG00015018492
Gene Symbol: LOC108919665
3 Cross references
236 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2-Like

Ensembl ID : ENSSFOG00015010991
Gene Symbol: LOC108935505
3 Cross references
236 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSSFOG00015018464
Gene Symbol: HCAR1
1 Cross references
240 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSFOG00015016207
Gene Symbol: HCN4
1 Cross references
285 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSFOG00015028540
Gene Symbol: HCN4
1 Cross references
285 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSSFOG00015013162
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSSFOG00015027505
Gene Symbol: LOC108928910
3 Cross references
212 Possible Orthologues:

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSSFOG00015031257
Gene Symbol: LOC108928909
3 Cross references
212 Possible Orthologues:

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSSFOG00015014015
Gene Symbol: LOC108928877
3 Cross references
212 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSSFOG00015028529
Gene Symbol: LOC108930426
3 Cross references
147 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).